Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
This article has been cited by
1Exploring the molecular mechanism of Panax notoginseng saponins on coronary atherosclerosis let-7b using miRNA
Xingli Liu,Wei Song,Jingsong Yang,Zihong Du,Fangmin Long,Hong Yao,Liang Lv
Journal of King Saud University - Science.2020;32(2)1707
[DOI]
2Analytical methods and biological activities of Panax notoginseng saponins: Recent trends
Congcong Xu,Weiwei Wang,Bing Wang,Tong Zhang,Xiuming Cui,Yiqiong Pu,Ning Li
Journal of Ethnopharmacology.2019;236(2)443
[DOI]
3Preparation, In Vivo and In Vitro Release of Polyethylene Glycol Monomethyl Ether-Polymandelic Acid Microspheres Loaded Panax Notoginseng Saponins
Yi He,Hongli Li,Xiangyu Zheng,Mingwei Yuan,Renyu Yang,Minglong Yuan,Cui Yang
Molecules.2019;24(10)2024
[DOI]
4Efficacy of Panax ginseng supplementation on blood lipid profile. A meta-analysis and systematic review of clinical randomized trials
Didier Hernández-García,Ana Belén Granado-Serrano,Meritxell Martín-Gari,Alba Naudí,Jose CE. Serrano
Journal of Ethnopharmacology.2019;243(10)112090
[DOI]
5Guggulsterone, a farnesoid X receptor antagonist lowers plasma trimethylamine-N-oxide levels: An evidence from in vitro and in vivo studies
A Gautam,YN Paudel,SAZ Abidin,U Bhandari
Human & Experimental Toxicology.2019;38(3)356
[DOI]
620(S)-Protopanaxadiol Saponins Mainly Contribute to the Anti-Atherogenic Effects of Panax notoginseng in ApoE Deficient Mice
Conghui Liu,Ruibing Feng,Jian Zou,Fangbo Xia,Jian-Bo Wan
Molecules.2019;24(20)3723
[DOI]
  Feedback 
  Subscribe